| Name | Title | Contact Details |
|---|
Evio is a pharmacy solutions startup that works with health plans to transform the medication experience for everyone: patients, providers, and the system at large.
PharmCentre is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wheel is the health tech company putting great care within everyone`s reach. We provide everything companies and clinicians need to serve patients virtually, including a complete virtual care platform and nationwide clinician network. Our offering makes it easy for companies to build virtual care services and for clinicians to manage their practice in one place — including onboarding, support, and the ability to work across several highly-vetted opportunities. Imagine a future without waiting rooms, where patients are quickly seen by the best clinician for their care need, who is happily working on their own schedule and on their own terms. That`s just a glimpse of the future we`re building—where everyone has access to equitable, high-quality care. Having already raised over $200 million in funding through top investors, including Lightspeed Venture Partners, Tiger Global, Coatue, and Salesforce Ventures, Wheel is, well, on a roll. We`re powering the most innovative companies in healthcare and racking up accolades like being named to Forbes` Next Billion-Dollar Startups and Built In`s Best Remote-First Places to Work. But our work is far from over. Embracing the full potential of virtual care is a challenging transition for a complex industry. We`re looking for bright, driven minds to help us solve problems and explore new possibilities for our platform. Become a Wheelie and use your skills to positively impact the health of millions. You`ll work alongside some of the most thoughtful go-getters in tech, at a company where care isn`t just our business, it`s our ethos. We value empathy, trust, and collaboration, with a healthy dose of tenacity and speed. Check out our careers page for our latest openings and join us in putting great care within everyone`s reach.
Sempre Health is bringing behavior-based, individualized copays to healthcare. Today, we work with health plans and pharma manufacturers to dynamically adjust copays based on individual adherence and behavior, seamlessly at the point of fill.
At Clinipace, a global, full-service contract research organization (CRO), our approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment. Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach. In April 2021, Clinipace & dMed merged creating a differentiated mid-size CRO with the largest Asia-Pacific presence. We are proud to have such a strong group of global investors focused on improving healthcare outcomes and giving sponsors a better CRO choice. dMed`s 2019 acquisition of Target Health commenced the process of building a Next Generation global CRO for biotech and pharmaceutical companies. Our investors have invested over $230M to build the next great global CRO. dMed`s acquisition of Target Health in 2019 began dMed`s evolution from a local to global CRO. Target Health LLC is owned by dMedClinical Co. Ltd., a privately held company that is majority owned, operated, managed, and controlled by a U.S. citizen and foreign entities located in the People`s Republic of China. Dr. Lingshi Tan, is the aforementioned U.S. citizen currently residing in Shanghai, China. Dr. Tan moved to Shanghai (from New York) to become Pfizer`s VP of Worldwide Development Operations, and Chairman and General Manager of Pfizer (China) Research & Development Co. Dr. Tan founded dMed in 2016 to satisfy the local demand for a high quality, responsive, flexible CRO.